Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature

References

• TrappBDNaveKAMultiple sclerosis: an immune or neurodegenerative disorder?Annu Rev Neurosci20083124726918558855
   PubMed Web of Science ®Google Scholar
• ConfavreuxCVukusicSNatural history of multiple sclerosis: a unifying conceptBrain2006129Pt 360661616415308
   PubMed Web of Science ®Google Scholar
• TullmanMJOverview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosisAm J Manag Care2013192 SupplS15S2023544716
   PubMed Web of Science ®Google Scholar
• MiloRKahanaEMultiple sclerosis: geoepidemiology, genetics and the environmentAutoimmun Rev201095A387A39419932200
   PubMed Web of Science ®Google Scholar
• KingwellEMarriottJJJettéNIncidence and prevalence of multiple sclerosis in Europe: a systematic reviewBMC Neurol20131312824070256
   PubMed Web of Science ®Google Scholar
• Alcalde-CaberoEAlmazán-IslaJGarcía-MerinoAde SáJde Pedro-CuestaJIncidence of multiple sclerosis among European Economic Area populations, 1985–2009: the framework for monitoringBMC Neurol2013135823758972
   PubMed Web of Science ®Google Scholar
• Benito-LeónJMultiple sclerosis: is prevalence rising and if so why?Neuroepidemiology201133–423623722133765
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAtlas: Multiple Sclerosis Resources in the World 2008Geneva, SwitzerlandWorld Health Organization2008 Available from: http://www.who.int/mental_health/neurology/Atlas_MS_WEB.pdfAccessed December 18, 2013
   Google Scholar
• KarampampaKGustavssonAMiltenburgerCEckertBTreatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countriesMult Scler2012182 Suppl71522623122
   PubMed Web of Science ®Google Scholar
• MarkowitzCEThe current landscape and unmet needs in multiple sclerosisAm J Manag Care2010168 SupplS211S21820873945
   PubMed Web of Science ®Google Scholar
• BandariDSSternamanDChanTProstkoCRSapirTEvaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosisJ Manag Care Pharm201218911723206263
   PubMed Web of Science ®Google Scholar
• SteinbergSCFarisRJChangCFChanATankersleyMAImpact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort studyClin Drug Investig201030289100
   PubMed Web of Science ®Google Scholar
• TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol2009256456857619444532
   PubMed Web of Science ®Google Scholar
• ZajicekJDiagnosis and disease modifying treatments in multiple sclerosisPostgrad Med J20058195955656116143683
   PubMed Web of Science ®Google Scholar
• Centre for Evidene-Based Medicine [homepage on the Internet]CEBMOxford, UKCentre for Evidence-Based Medicine2014 Available from: http://www.cebm.net/?o=1025Accessed June 5, 2014
   Google Scholar
• Web of Science [homepage on the Internet]Web of SciencePhiladelphia, PAThomson Reuters2014 Available from: http://wokinfo.com/Accessed June 5, 2014
   Google Scholar
• Google Scholar [homepage on the Internet]Google scholarMountain View, CAGoogle Inc.2014 Available from: http://scholar.google.es/Accessed June 5, 2014
   Google Scholar
• LehmannAAslaniPAhmedRAssessing medication adherence: options to considerInt J Clin Pharm2014361556924166659
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• MenzinJCaonCNicholsCWhiteLAFriedmanMPillMWNarrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJ Manag Care Pharm2013191 Suppl AS24S4023383731
   PubMed Web of Science ®Google Scholar
• NoseworthyJHLucchinettiCRodriguezMWeinshenkerBGMultiple sclerosisN Engl J Med20003431393895211006371
   PubMed Web of Science ®Google Scholar
• HirstCIngramGPearsonOPickersgillTScoldingNRobertsonNContribution of relapses to disability in multiple sclerosisJ Neurol2008255228028718204919
   PubMed Web of Science ®Google Scholar
• PattiFOptimizing the benefit of multiple sclerosis therapy: the importance of treatment adherencePatient Pref Adherence2010419
   PubMed Web of Science ®Google Scholar
• TanHCaiQAgarwalSStephensonJJKamatSImpact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosisAdv Ther2011281516121153000
   PubMed Web of Science ®Google Scholar
• IvanovaJIBergmanREBirnbaumHGPhillipsALStewartMMeleticheDMImpact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJ Med Econ201215360160922376190
   PubMedGoogle Scholar
• Oleen-BurkeyMADorACastelli-HaleyJLageMJThe relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetateJ Med Econ201114673974721913796
   PubMedGoogle Scholar
• TanHYuJTabbyDDevriesASingerJClinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort studyMult Scler201016895696320595246
   PubMed Web of Science ®Google Scholar
• SzkurhanAMalikSDembekCAgarwalSRajagopalanKRashidNEconomic impact of persistence to disease modifying therapies for the treatment of Multiple SclerosisValue Health2010137A250A480 Abstract
   Google Scholar
• BarbosaCDBalpMMKulichKGermainNRofailDA literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePatient Prefer Adherence20126394822272068
   PubMed Web of Science ®Google Scholar
• TworkSNippertISchererPHaasJPöhlauDKuglerJImmunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German multiple sclerosis populationCurr Med Res Opin20072361209121517559722
   PubMed Web of Science ®Google Scholar
• de SezeJBorgelFBrudonFPatient perceptions of multiple sclerosis and its treatmentPatient Prefer Adherence2012626327322536062
   PubMed Web of Science ®Google Scholar
• BeerKMüllerMHew-WinzelerAMThe prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational studyBMC Neurol20111114422074056
   PubMed Web of Science ®Google Scholar
• Verdun di CantognoERussellSSnowTUnderstanding and meeting injection device needs in multiple sclerosis: a survey of patient attitudes and practicesPatient Prefer Adherence2011517318021573048
   PubMed Web of Science ®Google Scholar
• JohnsonFRVan HoutvenGOzdemirSMultiple sclerosis patients’ benefit-risk preferences: serious adverse event risks versus treatment efficacyJ Neurol2009256455456219444531
   PubMed Web of Science ®Google Scholar
• SwinburnPShinglerSAliSPerardRLloydAPreferences of multiple sclerosis patients for attributes of self-injection devicesValue Health201215A1A276 Abstract
   Web of Science ®Google Scholar
• YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
   PubMed Web of Science ®Google Scholar
• O’BrienJAWardAJPatrickARCaroJCost of managing an episode of relapse in multiple sclerosis in the United StatesBMC Health Serv Res2003311712952552
   PubMed Web of Science ®Google Scholar
• LageMJCarrollCAFairmanKAUsing observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessmentJ Med Econ20131691146115323844620
   PubMedGoogle Scholar
• BruceJMHancockLMArnettPLynchSTreatment adherence in multiple sclerosis: association with emotional status, personality, and cognitionJ Behav Med201033321922720127401
   PubMed Web of Science ®Google Scholar
• StocklKMShinJSLewHCOutcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherenceJ Manag Care Pharm201016859360420866164
   PubMed Web of Science ®Google Scholar
• HalpernRBeckerLIgbalSUKazisLEMacariosDBadamgaravEThe association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosisJ Manag Care Pharm2011171253921204588
   PubMed Web of Science ®Google Scholar
• RoebuckMCLibermanJNGemmill-ToyamaMBrennanTAMedication adherence leads to lower health care use and costs despite increased drug spendingHealth Aff (Millwood)2011301919921209444
   PubMed Web of Science ®Google Scholar
• KirchhoffTRuofJMittendorfTCost of illness in rheumatoid arthritis in Germany in 1997–1998 and 2002: cost drivers and cost savingsRheumatology (Oxford)201150475676121149243
   PubMed Web of Science ®Google Scholar
• UmarNSchaarschmidtMSchmiederAPeitschWKSchöllgenITerrisDDMatching physicians’ treatment recommendations to patients’ treatment preferences is associated with improvement in treatment satisfactionJ Eur Acad Dermatol Venereol201327676377022631875
   PubMed Web of Science ®Google Scholar
• LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?Expert Opin Drug Deliv200969995100219637982
   PubMed Web of Science ®Google Scholar
• PalumboADe La FuentePRodríguezMWillingness to pay and conjoint analysis to determine women’s preferences for ovarian stimulating hormones in the treatment of infertility in SpainHum Reprod20112671790179821558333
   PubMed Web of Science ®Google Scholar
• SyedMRogDParkesLShepherdGLPatient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practicePatient Prefer Adherence2014824725524570582
   PubMed Web of Science ®Google Scholar
• DonovanKAGreenePGShusterJLPartridgeEETuckerDCTreatment preferences in recurrent ovarian cancerGynecol Oncol200286220021112144829
   PubMed Web of Science ®Google Scholar
• FriedTRByersALGalloWTProspective study of health status preferences and changes in preferences over time in older adultsArch Intern Med2006166889089516636215
   PubMed Web of Science ®Google Scholar